EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride): Technical Protocol Guidance

What This Product Solves

EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride, CAS 25952-53-8) addresses the critical requirement for a water-soluble carbodiimide reagent in modern peptide synthesis, bioconjugation, and nucleotide coupling workflows. As a peptide synthesis coupling reagent, it enables direct amide bond formation between carboxyl and primary amine groups under aqueous conditions. This bypasses the need for organic solvent-based coupling systems, simplifying downstream purification and minimizing side reactions. EDC.HCl is also employed as a bioconjugation reagent and in nucleotide synthesis for similar carboxyl-amine couplings, expanding its utility across biomolecular labeling and modification protocols.

Its water solubility and efficient activation of carboxyl groups make it particularly suitable for workflows aiming to maximize coupling efficiency while maintaining compatibility with sensitive biomolecules. The reagent is not recommended for in vivo or clinical use, as detailed in existing technical guidance, due to a lack of supporting safety and efficacy data.

Protocol Parameters

• Solubility in Water: ≥39 mg/mL | Use for all aqueous peptide synthesis and bioconjugation reactions | Guarantees reagent is fully in solution, minimizing precipitation and ensuring efficient activation of carboxyl groups | product information
• Storage Temperature (Solid): -20°C, desiccated | Long-term solid storage only | Prevents hydrolysis and degradation, preserving reagent activity for reproducible synthesis | product information
• Solution Stability: Avoid long-term solution storage | Prepare fresh solutions immediately before use | EDC.HCl is susceptible to hydrolysis in solution; degraded reagent leads to incomplete coupling and increased byproducts | product information
• Recommended Application: In vitro peptide synthesis, bioconjugation, nucleotide synthesis, esterification, lactonization | Do not use in in vivo or clinical protocols | EDC.HCl is validated for in vitro workflows; absence of safety data for other uses limits its scope | internal article
• Quantitative Monitoring: Spectrophotometric assay | Useful for reaction QC and confirmation of coupling reagent consumption | Allows real-time or endpoint tracking of EDC.HCl and byproduct | product information

Workflow Setup and QC Checklist

• Prepare EDC.HCl fresh for each use. Dissolve to the desired concentration (typically ≤39 mg/mL in water), ensuring full dissolution before combining with other reactants.
• Confirm all carboxyl-containing substrates and amine partners are compatible with aqueous buffers and that pH is within the range that supports carbodiimide activation (commonly pH 4.5–7.5; adjust based on substrate stability and workflow precedent).
• Keep all glassware and reaction vessels dry before weighing and handling the solid reagent. Avoid condensation or exposure to ambient humidity during manipulation.
• For bioconjugation and nucleotide synthesis applications, include a negative control lacking EDC.HCl to assess background reactivity.
• Monitor reaction progress by spectrophotometric analysis (e.g., monitoring urea byproduct formation or substrate depletion as appropriate for your system).
• Dispose of EDC.HCl waste and byproducts according to institutional chemical safety protocols.

For a detailed protocol setup tailored to in vitro workflows, refer to the Protocol and Technical Guide, which outlines stepwise controls for maximizing coupling efficiency and minimizing protocol failure.

Common Failure Modes and Fixes

• Incomplete Coupling: Often due to degraded or hydrolyzed EDC.HCl. Always prepare solutions fresh and avoid prolonged storage. Assess reagent quality by monitoring for expected byproduct formation.
• Precipitation in Solution: May occur if stock solution exceeds solubility limits or if buffer composition is incompatible. Redissolve below 39 mg/mL in water, and check for buffer components that may induce precipitation.
• High Background or Non-specific Conjugation: Excess EDC.HCl or prolonged incubation can cause side reactions. Optimize concentration and reaction time, and include appropriate controls to distinguish true positive signals.
• Product Hydrolysis: EDC.HCl is sensitive to moisture and hydrolyzes readily in aqueous media. Minimize exposure time, and store solid reagent in a desiccator at -20°C when not in use.

Scope and Limitations

EDC.HCl is validated for in vitro peptide synthesis, bioconjugation, nucleotide coupling, and related esterification and lactonization reactions. Its workflow suitability is restricted to laboratory bench use; there are no reported in vivo or clinical studies, and it should not be used in animal or human applications. The reagent's water solubility is a key advantage for biomolecule-compatible protocols, but hydrolysis and limited solution stability require stringent handling and fresh preparation. For comprehensive technical boundaries, see the Practical Guide, which further details correct in vitro-only application.

Conclusion

EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a robust amide bond formation reagent for in vitro peptide synthesis, bioconjugation, and nucleotide synthesis workflows. Its solubility in water and high reactivity under mild conditions enable precise coupling of carboxyl and amine groups, supporting efficient protocol execution. Strict adherence to storage and solution handling recommendations is required to ensure reproducibility and minimize side reactions. For full technical details and ordering information, consult the EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) product page at APExBIO.